Unchained Labs launches new automation software
October 20, 2021 -- Unchained Labs has released its LEA 10 automation software, which aims to enable researchers to navigate workflow bottlenecks and scientific challenges. Read More
Prime Medicine expands gene editing platform
October 19, 2021 -- Prime Medicine has added new capabilities to its Prime gene editing platform based on new research developments. Read More
Gamida highlights poster presentations at SITC 2021
October 19, 2021 -- Cell therapy firm Gamida Cell is directing attention to two poster presentations at the annual meeting of the Society for Immunotherapy of Cancer (SITC) involving its nicotinamide-enabled cell expansion technology. Read More
Stilla launches Naica 6-color digital PCR system
October 19, 2021 -- Stilla Technologies has launched Naica, a digital polymerase chain reaction (PCR) system that features six fluorescent channels. Naica was introduced at the American Society of Human Genetics virtual meeting. Read More
Exelixis, Storm to collaborate on cancer treatments
October 14, 2021 -- Exelixis and Storm Therapeutics have entered into an exclusive collaboration and license agreement to discover and develop new drug leads to treat cancer. Read More
Jackson Laboratory acquires Charles River Laboratories Japan
October 14, 2021 -- Biomedical research company the Jackson Laboratory has acquired Charles River Laboratories Japan's Research Models and Services business as a wholly owned subsidiary. Read More
Immusoft, Takeda ink metabolic disorder cell therapy deal
October 13, 2021 -- Immusoft has signed a research and licensing deal with Takeda Pharmaceutical to develop cell therapies for rare inherited metabolic disorders that have manifestations in the central nervous system. Read More
IMA Group acquires research site in Texas
October 13, 2021 -- The IMA Group has acquired Diagnostics Research Group, a clinical research site in San Antonio, TX. Read More
Twist Bioscience, Broad Institute partner
October 13, 2021 -- Twist Bioscience and the Broad Institute have created a custom next-generation sequencing target enrichment exome panel to be used to research cancer and rare and inherited disease genes. Read More
GeneCentric Therapeutics teams up with Labcorp
October 12, 2021 -- GeneCentric Therapeutics has formed a strategic partnership with Labcorp to develop and commercialize RNA-based gene signatures for oncology diagnostics. Read More
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter